Hydrolysis of triacylglycerol and uptake of fatty acids by suspensions of rat mammary cells
have shown that a fraction of the total lipoprotein lipase (EC 3.1.1.34) of lactating rat mammary tissue is associated with a preparation enriched in plasma-membrane fragments. Covalent-labelling experiments with non-permeant reagents (Clegp, 1979) have suggested that this plasma-membraneassmated lipoprotein lipase is an ectoprotein. The experiments reported here were done in order to provide additional information regarding the possible ectoprotein status of lipoprotein lipase by determining whether its catalytic site is accessible at the outer surface of the plasma membrane of rat mammary cells.
Dispersed cell preparations were made from abdominal mammary glands of rats in their loth-12th day of lactation, by the method of Greenbaum et al. (1978) . Radioactively labelled trioleoylglycerol stock emulsions m anhydrous glycerol were prepared as described by Nilsson-Ehle & Schotz (1976) ; they were diluted to working concentration, before being dispensed into individual incubation mixtures, with rat serum and SOmM-Tris/HCI, pH 8.1, containing 30mg of bovine serum albumin/ml as described by those authors. Cell suspensions were incubated in Krebs-Ringer bicarbonate medium (containing half the concentration of Ca2+ recommended in the original Krebs-Ringer formulation) containing 2% (w/v) Ficoll, 10 mg of defatted bovine serum albumin/ml and triacylglycerol as indicated in Fig. 1 , under a gas phase of O,/CO, (19: 1). Cells and medium were separated by centrifugation followed by three washing cycles of resuspension in fresh medium and resedimentation. Non-esterified fatty acid was extracted by the method of Belfrage & Vaughan (1969) . Routine procedures were used for the preparation of aqueous and non-aqueous liquid samples and cell-containing samples for radioactive counting.
The results in Fig. l(a) show that association of radioactivity with cells increased with time during incubation with triI'H1-oleoylglycerol. Little or no unesterified [ 3Hloleate was detectable in the total incubation (cells plus medium) throughout the experiment. Lipid class analysis by chromatography on thin (0.5 mm) silica layers (developing solvent hexaneldiethyl ether/formic acid, 40: 10: 1, by vol.) revealed that over 88% of the radioactivity associated with the re-isolated cells was in the form of triacylglycerol (results not shown). The trivial explanation for these results is that the triacylglycerol presented to the cells physically adheres to them and that the extent of this adhesion increases with time. To test this, an experiment was performed exactly as above but in which the substrate provided was trioleoyl1 'Hlglycerol ( Fig. 1 b) . No association of radioactivity with re-isolated cells resulted from this incubation, and there was a linear increase in the concentration of ['Hlglycerol in the medium. Therefore the uptake of radioactivity observed in the first experiment must have resulted from an initial extracellular hydrolysis of triacylglycerol to fatty acid followed by uptake and re-esterification of fatty acid to triacylglycerol within the cells. The rate-limiting reaction in this sequence was evidently the initial hydrolysis, since unesterified fatty acid was not detectable either in the medium or in the cells. Furthermore, the addition of non-radioactive oleate to the medium did not decrease the rate of uptake of radioactivity, indicating that fatty acid liberated by the hydrolysis is not miscible with the extracellular fatty acid-albumin complex, and is preferentially taken up by the cells. Either the hydrolytic enzyme delivers the fatty acid directly to its transmembrane transport mechanism (whatever that may be; see, e.g., Samuel et al., 1976) or itself acts as a transporter delivering fatty acid at the cytoplasmic surface of the plasma membrane.
Two observations support the identification of membranebound lipoprotein lipase as the hydrolytic enzyme in question. Firstly, the kinetics of the uptake of radioactivity from tri[ 3Hloleoylglycerol are significantly m d i e d when serum is omitted from the substrate (Fig. la) . Secondly little tri- Monoclonal antibodies from hybrid myelomas offer a powerful approach to the biochemistry of cell-surface components and the identification and marking of different types of cell (Milstein et al., 1979) . Hybrid myelomas are made by hybridizing antibody-secreting spleen cells from an immunized mouse with a myeloma cell line that can be grown in culture or passaged in mice. The resulting hybrids make antibody molecules of a unique amino acid sequence specified by the spleen cell. Hybrid myelomas were made producing monoclonal antibodies to surface molecules of the human erythrocyte. Hybrids LICR LON/RlO, R20.16 and R18 were made by fusing spleen cells from mice immunized with human erythrocytes with the mouse myeloma NS 1, with poly(ethy1ene glycol) as described by Galfre et al. (1977) , except that they were cloned from the outset in soft agar. The air-buffered medium L1S (Leibovitz, 1963) was used, and after dilution of the poly(ethy1ene glycol) and centrifugation, cells were resuspended with LO6 thymocytes/ml as a feeder (Andersson et al., 1977) in 0.25% (w/v) agar, in Ll5 medium + 20% h/v) foetal-calf serum and 0.5 ml portions were put in each of 48 2 cm2 agar-subbed wells. When the agar was set it was overlaid with 1.5 ml of Dulbecco's medium (Smith et al., 1Y60) with serum and HAT (Littlefield, 1964) . Visible hybrid colonies were picked from the agar 11 days after fusion, and tested for production of anti-erythrocyte antibody 4 days later. (6) precipitates with antibodies R20.16 and R6A; (7) as (2) on a separate gel, with (8) precipitate with antibody R10; (9) as (8) with added membrane. Tracks 1-4 exposed 4 h, 5-9 for 18 h. All were later recloned by dilution to single cells in 96-well microtest plates on a thymocyte-feeder layer. Hybrid R6A was made the same way but the agar was omitted. Antibodies to the erythrocyte cell surface were detected by incubating medium samples with 2 x lo7 erythrocytes, washing the cells, incubating with 112s-labelled F(ab), fragment of rabbit anti-(mouse immunoglobulin G) antibody, washing and determining radioactivity bound to the cells (trace assay of Williams et al., 1977).
Antibodies from 15 hybrids were tested for their ability to precipitate erythrocyte-membrane components. About lo* erythrocytes were surface-labelled with 12$1 by using lactoperoxidase and were solubilized in Iml of 1% (w/v) deoxycholate in 15OmM-NaCl/SOmM-Tris/HCl (pH 8.0 at 4OC).
After centrifugation for 1 h at 35000g,,., 100pl samples were incubated with 2 0 0~1 of ten-times-concentrated supernatant from a hybrid culture, followed by 2 0 0~1 of rabbit anti-(mouse immunoglobulin G) serum overnight in the same buffer, 0.5% deoxycholate. Precipitates were washed and were electrophoresed on sodium dodecyl sulphate/ 10% (w/v) polyacrylamide gels (Laemmli, 1970) . Two antibodies gave clear precipitates of the glycoprotein Band 3 and three precipitated glycophorin A. Two of each are shown in Fig. 1 . The sialoglycoproteins are identified by their dimerization at high loadings (Anstee & Tanner, 1979) (compare track 1 with track 2, where extra membrane has been added). The bands precipitafed by antibodies R10 and R18 are glycophorin A monoMr and dimer. The high-molecular-weight material precipitated-by antibodies R6A and R20.16 is probably aggregated Band 3 glycoprotein.
The anti-(glycophorin A) antibody R10, when tested by fluorescence or immunohistochemical staining on bone marrow, appears specific for erythrocytes and a population of nucleated cells throught to be erythrocyte precursors, paralleling the distribution of glycophorin A (Gahmberg et al., 1978) . On sections of other tissues it also appears specific for erythrocytes.
The anti-(Band 3 glycoprotein) antibody R6A binds to a similar population of cells in bone marrow, so may well be specifrc for Band 3. In contrast, antibody R20.16, the other anti-(Band 3 glycoprotein) antibody, stains all bone-marrow cells uniformly and binds strongly to other human cells, e.g. peripheral lymphocytes and the breast-tumour-epithelial-cell line MCF7 (Soule et al., 1973) . This probably reflects one limitation of monoclonal antibodies, that they are only specific for a cell-surface molecule if the particular antigenic determinant they bind to is unique to that molecule. Probably R20.16 antibody binds to a site on Band 3 glycoprotein that is also found on different molecules on other cells. 
